CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
406-420 of 1027
Updates in Limited-Stage Small Cell Lung Cancer (LS-SCLC)
MinuteCE®Updates in Limited-Stage Small Cell Lung Cancer (LS-SCLC)
Stephen Liu, MD
Joshua K. Sabari, MD
Susan Scott, MD
Clinical Implications of Neoadjuvant Therapy Guideline Updates in Resectable Melanoma
MinuteCE®Clinical Implications of Neoadjuvant Therapy Guideline Updates in Resectable Melanoma
John M. Kirkwood, MD
Sapna Patel, MD
Strategies in EGFR-mutated Unresectable Stage III NSCLC
MinuteCE®Strategies in EGFR-mutated Unresectable Stage III NSCLC
Stephen Liu, MD
Joshua K. Sabari, MD
Susan Scott, MD
Emerging Therapeutic Developments in Non-Targetable Metastatic NSCLC
MinuteCE®Emerging Therapeutic Developments in Non-Targetable Metastatic NSCLC
Stephen Liu, MD
Joshua K. Sabari, MD
Susan Scott, MD
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed Stage III Melanoma
MinuteCE®Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed Stage III Melanoma
Paolo A. Ascierto, MD
Hussein Tawbi, MD, PhD
Clinical Data Prompting Guideline Updates for Subcutaneous ICIs in Melanoma
MinuteCE®Clinical Data Prompting Guideline Updates for Subcutaneous ICIs in Melanoma
Hussein Tawbi, MD, PhD
Sapna Patel, MD
- advertisement
Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage III/IV Melanoma
MinuteCE®Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage III/IV Melanoma
Paolo A. Ascierto, MD
Hussein Tawbi, MD, PhD
Data Driving Preferred Guideline Recommendations in First-Line Therapy for Metastatic Melanoma
MinuteCE®Data Driving Preferred Guideline Recommendations in First-Line Therapy for Metastatic Melanoma
Paolo A. Ascierto, MD
Hussein Tawbi, MD, PhD
The Current Therapeutic Landscape in Unresectable Stage III NSCLC
MinuteCE®The Current Therapeutic Landscape in Unresectable Stage III NSCLC
Stephen Liu, MD
Joshua K. Sabari, MD
Susan Scott, MD
Stephen Liu, MD
Joshua K. Sabari, MD
Susan Scott, MD
John M. Kirkwood, MD
Paolo A. Ascierto, MD
Hussein Tawbi, MD, PhD
Sapna Patel, MD
Applications of Emerging Data in Resectable NSCLC
MinuteCE®Applications of Emerging Data in Resectable NSCLC
Stephen Liu, MD
Joshua K. Sabari, MD
Susan Scott, MD
- advertisement
Insights From Global Key Opinion Leaders on Regional Regulatory and Guideline Nuances to Optimize Melanoma Management
MinuteCE®Insights From Global Key Opinion Leaders on Regional Regulatory and Guideline Nuances to Optimize Melanoma Management
Hussein Tawbi, MD, PhD
Paolo A. Ascierto, MD
Emerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
MinuteCE®Emerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
Sapna Patel, MD
John M. Kirkwood, MD
Novel Therapies in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
MinuteCE®Novel Therapies in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Stephen Liu, MD
Joshua K. Sabari, MD
Susan Scott, MD
